These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3290485)

  • 21. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
    Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
    Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
    Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
    J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new class of orally active glycol renin inhibitors containing phenyllactic acid at P3.
    Hanson GJ; Baran JS; Lowrie HS; Russell MA; Sarussi SJ; Williams K; Babler M; Bittner SE; Papaioannou SE; Yang PC
    Biochem Biophys Res Commun; 1989 Apr; 160(1):1-5. PubMed ID: 2496685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antiviral activity, and bioavailability studies of gamma-lactam derived HIV protease inhibitors.
    Hungate RW; Chen JL; Starbuck KE; Vacca JP; McDaniel SL; Levin RB; Dorsey BD; Guare JP; Holloway MK; Whitter W
    Bioorg Med Chem; 1994 Sep; 2(9):859-79. PubMed ID: 7712123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
    Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
    J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
    Hui KY; Carlson WD; Bernatowicz MS; Haber E
    J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T3P-Promoted, Mild, One-Pot Syntheses of Constrained Polycyclic Lactam Dipeptide Analogues via Stereoselective Pictet-Spengler and Meyers Lactamization Reactions.
    Jida M; Van der Poorten O; Guillemyn K; Urbanczyk-Lipkowska Z; Tourwé D; Ballet S
    Org Lett; 2015 Sep; 17(18):4482-5. PubMed ID: 26322913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties.
    Boyd SA; Fung AK; Baker WR; Mantei RA; Armiger YL; Stein HH; Cohen J; Egan DA; Barlow JL; Klinghofer V
    J Med Chem; 1992 May; 35(10):1735-46. PubMed ID: 1588555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.
    Sham HL; Bolis G; Stein HH; Fesik SW; Marcotte PA; Plattner JJ; Rempel CA; Greer J
    J Med Chem; 1988 Feb; 31(2):284-95. PubMed ID: 3276890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric synthesis of gamma-keto-delta-lactam derivatives: application to the synthesis of a conformationally constrained surrogate of Ala-Ser dipeptide.
    Koulocheri SD; Magiatis P; Haroutounian SA
    J Org Chem; 2001 Nov; 66(23):7915-8. PubMed ID: 11701060
    [No Abstract]   [Full Text] [Related]  

  • 31. Conformational aspects of angiotensinogen analogues with renin inhibitory activity.
    Liepina I; Nikiforovich GV; Paiva AC
    Biochem Biophys Res Commun; 1984 Jul; 122(2):700-5. PubMed ID: 6380499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactam-conformationally restricted analogs of N alpha-arylsulfonyl arginine amide: design, synthesis and inhibitory activity toward thrombin and related enzymes.
    Okayama T; Seki S; Ito H; Takeshima T; Hagiwara M; Morikawa T
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1683-91. PubMed ID: 8536341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies directed toward the design of orally active renin inhibitors. 1. Some factors influencing the absorption of small peptides.
    Rosenberg SH; Spina KP; Woods KW; Polakowski J; Martin DL; Yao Z; Stein HH; Cohen J; Barlow JL; Egan DA
    J Med Chem; 1993 Feb; 36(4):449-59. PubMed ID: 8474101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives.
    Bradbury RH; Major JS; Oldham AA; Rivett JE; Roberts DA; Slater AM; Timms D; Waterson D
    J Med Chem; 1990 Sep; 33(9):2335-42. PubMed ID: 2118184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
    Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
    J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.
    Holladay MW; Salituro FG; Rich DH
    J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel small renin inhibitors containing 4,5- or 3,5-dihydroxy-2-substituted-6-phenylhexanamide replacements at the P2-P3 sites.
    Jung GL; Anderson PC; Bailey M; Baillet M; Bantle GW; Berthiaume S; Lavallée P; Llinas-Brunet M; Thavonekham B; Thibeault D; Simoneau B
    Bioorg Med Chem; 1998 Dec; 6(12):2317-36. PubMed ID: 9925293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.